August 5, 2020
Session two will describe the latest scientific advances, approaches, and specific tools and actions available for utilization at the country/local level.
About the series:
In 2018, according to the World Health Organization (WHO), approximately 570,000 women worldwide were diagnosed with cervical cancer. A shocking 311,000 women died of the disease. More than 80% of them were from low- and middle-income countries. While high-level institutions including the WHO are calling for action, it is crucial to understand the research, scientific advances, policy implementation considerations, and strategic coordination that are needed to reduce cervical cancer at the local and global level. A whole of society approach is required to reduce this disease, a preventable and treatable malignancy. This three-part webinar series brings together experts from the fields of research, clinical care, and policy, to debate and discuss what it will take to effectively reduce the global cervical cancer burden.
Mark Schiffman, MD, MPH
Senior Investigator, Division of Cancer Epidemiology and Genetics, US National Cancer Institute, USA
Nicole Gastineau Campos, PhD
Senior Research Scientist, Center for Health Decision Science, Harvard T.H. Chan School of Public Health, USA
Ophira Ginsburg, MSc, MD
Associate Professor, Department of Population Health, Associate Professor, NYU Grossman School of Medicine
Anne F Rositch, MSPH, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
Isaac F Adewole, MD
Professor, Obstetrics and Gynaecology University of Ibadan